Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ 644 Cystic Fibrosis 40plus4 Control
A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing
Supplier: SeraCare™ 20400015
Description
- Identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
- Covers all 47 mutations in the Prima xTAG™ CFTR IVD Assay
- Eliminate errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
- Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
- All mutations contained in a single vial
- High purity, large lots, stable materials–no additional processing required
Not for use in diagnostic procedures
Specifications
| CE, RUO | |
| ACCURUN 644 Cystic Fibrosis 40+4 Control | |
| Detects significant errors with the use of rotating gDNA control schemes, research use only | |
| 100 μL |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction